TABLE 1.
Strain | Amino acid change at the indicated position in the QRDR ofa:
|
MIC (μg/ml)b of:
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GyrA
|
ParC
|
ParE
|
TVA | SPX | CIP | OFX | NOR | PEF | ||||||
153 | 157 | 189 | 91 | 92 | 95 | 446 | 466 | |||||||
PG21 (reference strain) | Ser | Glu | Ala | Ser | Ser | Glu | Leu | Glu | 0.06 | 0.06 | 2 | 1 | 32 | 4 |
First-step mutants | ||||||||||||||
IT1 | —c | — | — | — | — | — | — | Lys | 0.25 | 0.12 | 8 | 2 | 128 | 4 |
IT2 | — | — | — | — | — | — | — | Lys | 0.25 | 0.12 | 8 | 2 | 128 | 4 |
IT3 | — | — | — | — | — | — | — | Lys | 0.25 | 0.12 | 8 | 2 | 128 | 4 |
Second-step mutants | ||||||||||||||
IIT2A | — | — | Val | — | — | — | — | Lys | 0.5 | 0.12 | 8 | 1 | 128 | 4 |
IIT2B | Leu | — | — | — | — | — | — | Lys | 2 | 1 | 32 | 2 | 128 | 4 |
IIT2C | Leu | — | — | — | — | — | — | Lys | 2 | 1 | 32 | 2 | 128 | 4 |
IIT2D | Leu | — | — | — | — | — | — | Lys | 2 | 1 | 32 | 2 | 128 | 4 |
IIT2E | Leu | — | — | — | — | — | — | Lys | 2 | 1 | 32 | 2 | 128 | 4 |
IIT2F | Leu | — | — | — | — | — | — | Lys | 2 | 1 | 32 | 2 | 128 | 4 |
IIT3A | — | — | Glu | — | — | — | — | Lys | 1 | 0.5 | 16 | 2 | 128 | 4 |
IIT3B | — | — | Glu | — | — | — | — | Lys | 1 | 0.5 | 16 | 2 | 128 | 4 |
IIT3C | — | Lys | — | — | — | — | — | Lys | 1 | 1 | 16 | 2 | 128 | 4 |
IIT3D | — | — | Glu | — | — | — | — | Lys | 1 | 0.5 | 16 | 2 | 128 | 4 |
IIT3E | — | — | Glu | — | — | — | — | Lys | 1 | 0.5 | 16 | 2 | 128 | 4 |
IIT3F | — | — | Glu | — | — | — | — | Lys | 1 | 0.5 | 16 | 2 | 128 | 4 |
Third-step mutants | ||||||||||||||
IIIT2D1 | Leu | — | — | — | Pro | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2D2 | Leu | — | — | Ile | — | — | — | Lys | 16 | 32 | 128 | 64 | >128 | 32 |
IIIT2D3 | Leu | — | — | — | — | Gln | — | Lys | 8 | 8 | 32 | 16 | >128 | 16 |
IIIT2F1 | Leu | — | — | — | — | — | Phe | Lys | 16 | 32 | 128 | 64 | >128 | 32 |
IIIT2F2 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | 128 | 64 | >128 | 32 |
IIIT2F3 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F4 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F5 | Leu | — | — | — | — | — | Phe | Lys | 16 | 64 | 128 | 64 | >128 | 32 |
IIIT2F6 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F7 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F8 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F9 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F10 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | >128 | 64 | >128 | 32 |
IIIT2F11 | Leu | — | — | Ile | — | — | — | Lys | 16 | 64 | 128 | 64 | >128 | 32 |
GyrA, ParC, and ParE residue positions are based on the respective gene sequences for M. hominis (4; this study). GyrA positions 153, 157, and 189 correspond to E. coli coordinates 83, 87, and 119, respectively. ParC positions 91, 92, and 95 correspond to E. coli coordinates 80, 81, and 84, respectively. ParE positions 446 and 466 correspond to E. coli coordinates 440 and 460, respectively.
TVA, trovafloxacin; SPX, sparfloxacin; CIP, ciprofloxacin; OFX, ofloxacin; NOR, norfloxacin; PEF, pefloxacin.
—, identical to that in the reference strain, PG21.